CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

References

• Lusis AJ Atherosclerosis Nature 2000 407 6801 233 241 11001066
   PubMed Web of Science ®Google Scholar
• Hansson GK Libby P The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 2006 6 7 508 519 16778830
   PubMed Web of Science ®Google Scholar
• Virmani R Kolodgie FD Burke AP Farb A Schwartz SM Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 2000 20 5 1262 1275 10807742
   PubMed Web of Science ®Google Scholar
• Ross R Atherosclerosis – an inflammatory disease N Engl J Med 1999 340 2 115 126 9887164
   PubMed Web of Science ®Google Scholar
• Ross R The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 1993 362 6423 801 809 8479518
   PubMed Web of Science ®Google Scholar
• Libby P Inflammation in atherosclerosis Nature 2002 420 6917 868 874 12490960
   PubMed Web of Science ®Google Scholar
• Erbel C Sato K Meyer FB Functional profile of activated dendritic cells in unstable atherosclerotic plaque Basic Res Cardiol 2007 102 2 123 132 17136419
   PubMed Web of Science ®Google Scholar
• Erbel C Dengler TJ Wangler S Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability Basic Res Cardiol 2011 106 1 125 134 21116822
   PubMed Web of Science ®Google Scholar
• Boring L Gosling J Cleary M Charo IF Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis Nature 1998 394 6696 894 897 9732872
   PubMed Web of Science ®Google Scholar
• Aukrust P Berge RK Ueland T Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes J Am Coll Cardiol 2001 37 2 485 491 11216967
   PubMed Web of Science ®Google Scholar
• Burman A Haworth O Hardie DL A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis J Immunol 2005 174 3 1693 1700 15661933
   PubMed Web of Science ®Google Scholar
• Middel P Raddatz D Gunawan B Haller F Radzun HJ Increased number of mature dendritic cells in Crohn’s disease: evidence for a chemokine mediated retention mechanism Gut 2006 55 2 220 227 16118351
   PubMed Web of Science ®Google Scholar
• Ngo VN Tang HL Cyster JG Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells J Exp Med 1998 188 1 181 191 9653094
   PubMed Web of Science ®Google Scholar
• Luther SA Tang HL Hyman PL Farr AG Cyster JG Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse Proc Natl Acad Sci U S A 2000 97 23 12694 12699 11070085
   PubMed Web of Science ®Google Scholar
• Gunn MD Tangemann K Tam C Cyster JG Rosen SD Williams LT A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes Proc Natl Acad Sci U S A 1998 95 1 258 263 9419363
   PubMed Web of Science ®Google Scholar
• Vassileva G Soto H Zlotnik A The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes J Exp Med 1999 190 8 1183 1188 10523616
   PubMed Web of Science ®Google Scholar
• Nakano H Gunn MD Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation J Immunol 2001 166 1 361 369 11123313
   PubMed Web of Science ®Google Scholar
• Mori S Nakano H Aritomi K Wang CR Gunn MD Kakiuchi T Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses J Exp Med 2001 193 2 207 218 11148224
   PubMed Web of Science ®Google Scholar
• Gunn MD Kyuwa S Tam C Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization J Exp Med 1999 189 3 451 460 9927507
   PubMed Web of Science ®Google Scholar
• Förster R Davalos-Misslitz AC Rot A CCR7 and its ligands: balancing immunity and tolerance Nat Rev Immunol 2008 8 5 362 371 18379575
   PubMed Web of Science ®Google Scholar
• Xu B Aoyama K Kusumoto M Lack of lymphoid chemokines CCL19 and CCL21 enhances allergic airway inflammation in mice Int Immunol 2007 19 6 775 784 17513879
   PubMed Web of Science ®Google Scholar
• Damås JK Smith C Øie E Enhanced expression of the homeo-static chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization Arterioscler Thromb Vasc Biol 2007 27 3 614 620 17170367
   PubMed Web of Science ®Google Scholar
• Halvorsen B Dahl TB Smedbakken LM Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells Cardiovasc Res 2014 102 1 148 156 24518141
   PubMed Web of Science ®Google Scholar
• Erbel C Chen L Bea F Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice J Immunol 2009 183 12 8167 8175 20007582
   PubMed Web of Science ®Google Scholar
• Nakashima Y Plump AS Raines EW Breslow JL Ross R ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree Arterioscler Thromb 1994 14 1 133 140 8274468
   PubMed Web of Science ®Google Scholar
• Klingenberg R Nofer JR Rudling M Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice Arterioscler Thromb Vasc Biol 2007 27 11 2392 2399 17761943
   PubMed Web of Science ®Google Scholar
• Gleissner CA Shaked I Little KM Ley K CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages J Immunol 2010 184 9 4810 4818 20335529
   PubMed Web of Science ®Google Scholar
• Moore KJ Sheedy FJ Fisher EA Macrophages in atherosclerosis: a dynamic balance Nat Rev Immunol 2013 13 10 709 721 23995626
   PubMed Web of Science ®Google Scholar
• Go AS Mozaffarian D Roger VL Executive summary: heart disease and stroke statistics – 2014 update: a report from the American Heart Association Circulation 2014 129 3 399 410 24446411
   PubMed Web of Science ®Google Scholar
• Murray CJ Lopez AD Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study Lancet 1997 349 9063 1436 1442 9164317
   PubMed Web of Science ®Google Scholar
• Myerburg RJ Interian AJr Mitrani RM Kessler KM Castellanos A Frequency of sudden cardiac death and profiles of risk Am J Cardiol 1997 80 5B 10F 19F
   Web of Science ®Google Scholar
• Naghavi M Libby P Falk E From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I Circulation 2003 108 14 1664 1672 14530185
   PubMed Web of Science ®Google Scholar
• Swirski FK Pittet MJ Kircher MF Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease Proc Natl Acad Sci U S A 2006 103 27 10340 10345 16801531
   PubMed Web of Science ®Google Scholar
• Libby P Ridker PM Maseri A Inflammation and atherosclerosis Circulation 2002 105 9 1135 1143 11877368
   PubMed Web of Science ®Google Scholar
• Tomey MI Narula J Kovacic JC Advances in the understanding of plaque composition and treatment options: year in review J Am Coll Cardiol 2014 63 16 1604 1616 24583311
   PubMed Web of Science ®Google Scholar
• Gleissner CA Shaked I Erbel C Bockler D Katus HA Ley K CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages Circ Res 2010 106 1 203 211 19910578
   PubMed Web of Science ®Google Scholar
• Newby AC Metalloproteinases and vulnerable atherosclerotic plaques Trends Cardiovasc Med 2007 17 8 253 258 18021934
   PubMed Web of Science ®Google Scholar
• Sakakura K Nakano M Otsuka F Ladich E Kolodgie FD Virmani R Pathophysiology of atherosclerosis plaque progression Heart Lung Circ 2013 22 6 399 411 23541627
   PubMed Web of Science ®Google Scholar
• Forster R Schubel A Breitfeld D CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs Cell 1999 99 1 23 33 10520991
   PubMed Web of Science ®Google Scholar
• Weninger W Carlsen HS Goodarzi M Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis J Immunol 2003 170 9 4638 4648 12707342
   PubMed Web of Science ®Google Scholar
• Chen SC Vassileva G Kinsley D Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice J Immunol 2002 168 3 1001 1008 11801632
   PubMed Web of Science ®Google Scholar
• Wengner AM Hopken UE Petrow PK CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis Arthritis Rheum 2007 56 10 3271 3283 17907173
   PubMed Web of Science ®Google Scholar
• Luther SA Bidgol A Hargreaves DC Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis J Immunol 2002 169 1 424 433 12077273
   PubMed Web of Science ®Google Scholar
• Link A Vogt TK Favre S Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells Nat Immunol 2007 8 11 1255 1265 17893676
   PubMed Web of Science ®Google Scholar
• Marsland BJ Battig P Bauer M CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells Immunity 2005 22 4 493 505 15845453
   PubMed Web of Science ®Google Scholar
• Debes GF Arnold CN Young AJ Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues Nat Immunol 2005 6 9 889 894 16116468
   PubMed Web of Science ®Google Scholar